Ozempic, Wegovy get new rivals as Kenya approves seven Semaglutide drugs Health Just now

Kenya's drug regulator has registered seven semaglutide products for the treatment of type 2 diabetes and weight management, as experts warn of rising obesity and diabetes cases in the country.

What you need to know: Kenya has registered seven semaglutide products for the treatment of type 2 diabetes and weight management.

Acharya says the drug can treat both diabetes and obesity, helping patients feel full faster and reducing cravings, which leads to significant weight loss.